PPARs and Mitochondrial Metabolism: From NAFLD to HCC
Tommaso Mello1, Maria Materozzi1, Andrea Galli2
1Clinical Gastroenterology Unit, Department of Biomedical Clinical and Experimental Sciences "Mario Serio", University of Florence, Viale Pieraccini 6, 50129 Florence, Italy.
Nuclear receptors, Peroxisome proliferator-activated receptors (PPARs), regulate liver mitochondrial metabolism. This review explores their role in metabolic diseases like nonalcoholic fatty liver disease (NAFLD) and liver cancer (HCC).
Area of Science:
- Hepatology
- Mitochondrial Biology
- Endocrinology
Background:
- Metabolic diseases like type 2 diabetes, metabolic syndrome, and NAFLD cause significant global mortality, primarily from cardiovascular events and cancer.
- The liver, as the central metabolic organ, plays a crucial role in maintaining whole-body energy homeostasis.
- Mitochondria are key cellular hubs integrating metabolic, hormonal, and inflammatory signals essential for cellular energy and biosynthesis.
Purpose of the Study:
- To review the critical roles of Peroxisome proliferator-activated receptors (PPARs) in regulating liver mitochondrial metabolism.
- To explore the involvement of PPARs in both physiological functions and pathological conditions, including nonalcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC).
Main Methods:
- Literature review focusing on the function of PPARs in liver metabolism.
- Analysis of studies investigating PPARs' impact on mitochondrial function in various liver conditions.
- Synthesis of current knowledge on PPARs' regulatory mechanisms in hepatic energy homeostasis.
Main Results:
- PPARs are key nuclear receptors that orchestrate lipid and glucose metabolism.
- PPARs significantly influence liver mitochondrial function, impacting energy production and substrate utilization.
- Dysregulation of PPARs is implicated in the pathogenesis of metabolic disorders and liver cancer.
Conclusions:
- PPARs are central regulators of liver mitochondrial metabolism.
- Understanding PPARs' function is crucial for developing therapeutic strategies against metabolic diseases and liver cancer.
- Further research into PPARs' pathways can elucidate mechanisms underlying NAFLD and HCC progression.
More Related Videos
08:39Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
